Boston University Medical Campus

Mission Statement

The BU CTSI’s vision is to be the strongest possible advocate for, and participant in, translational research that serves the health needs of our diverse patient populations by working with our community to create unique resources that can be integrated with and distributed to the national CTSA network.

At a Glance

0

Educational Resources Posted

1

Consortium News Stories Posted

1

Events Posted

0

Opportunities Posted

Coming Soon

Publications citing CTSA Program Grant

12

Users from Hub Registered
Programs

UL1 Award

KL2 Award

TL1 Award

Funded Years
2012 - 2013, 2015 - 2018, 2020
Connect with Us
Page Administrators
Helia M
Morris
Executive Director

The Boston University Clinical Translational Science Institute (BU-CTSI) is holding their 8th Annual David Seldin Memorial Translational Science Symposium: “From Server to Bedside: Advancing Health and Healthcare Through Data Science.”

The Boston University Clinical Translational Science Institute (BU-CTSI) is holding their 8th Annual David Seldin Memorial Translational Science Symposium: “From Server to Bedside: Advancing Health and Healthcare Through Data Science.” The day is organized around three general themes: Foundational

SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response

A hallmark of severe COVID-19 pneumonia is SARS-CoV-2 infection of the facultative progenitors of lung alveoli, the alveolar epithelial type 2 cells (AT2s). However, inability to access these cells from patients, particularly at early stages of disease, limits an understanding of disease inception